We are live on ! Find out more
SA

Shilanski & Associates Portfolio holdings

AUM $376M
1-Year Est. Return 19.08%
This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
+19.08%
3 Year Est. Return
+84.25%
5 Year Est. Return
+122.72%
10 Year Est. Return
–
AUM
$350M
AUM Growth
+$29.5M
Cap. Flow
+$4.37M
Cap. Flow %
1.25%
Top 10 Hldgs %
42.84%
Holding
109
New
5
Increased
54
Reduced
45
Closed
1

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$963K
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$713K
3
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$259K
4
SRLN icon
State Street Blackstone Senior Loan ETF
SRLN
+$241K
5
ORCL icon
Oracle
ORCL
+$222K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$215K
2
AAPL icon
Apple
AAPL
+$174K
3
PM icon
Philip Morris
PM
+$125K
4
ABBV icon
AbbVie
ABBV
+$106K
5
IBM icon
IBM
IBM
+$88.6K

Sector Composition

Rank Sector Weight
1 Technology 11.66%
2 Consumer Staples 8.09%
3 Financials 7.19%
4 Industrials 6.9%
5 Utilities 5.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
101
Amgen
AMGN
$209B
$210K 0.06%
752
-1
-0.1% -$283
UNH icon
102
UnitedHealth
UNH
$382B
$209K 0.06%
669
-9
-1% -$3.44K
IWM icon
103
iShares Russell 2000 ETF
IWM
$79.1B
$205K 0.06%
+951
New +$191K
VTI icon
104
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
$202K 0.06%
+661
New +$186K
MMYT icon
105
MakeMyTrip
MMYT
$5.38B
$200K 0.06%
+2,042
New +$206K
AEG icon
106
Aegon
AEG
$13.3B
$193K 0.06%
25,849
-49
-0.2% -$328
PSO icon
107
Pearson
PSO
$10.6B
$176K 0.05%
11,755
+54
+0.5% +$840
TEVA icon
108
Teva Pharmaceuticals
TEVA
$40.4B
$170K 0.05%
10,115
-133
-1% -$2.15K
MRK icon
109
Merck
MRK
$322B
– –
-2,400
Closed -$215K
1 2 3 4
5

Similar funds

NELSF
NewGen Equity Long/Short Fund Grand Cayman, Cayman Islands $374M AUM
MFGP
Marshall Financial Group (Pennsylvania) Doylestown, Pennsylvania $364M AUM 12.86% 1-Year Est. Return
BCCM
Bridge Creek Capital Management West Barnstable, Massachusetts $360M AUM 16.27% 1-Year Est. Return
PA
Pineridge Advisors St. Charles, Missouri $350M AUM 6.38% 1-Year Est. Return
BWA
Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return
PAWA
Palo Alto Wealth Advisors Palo Alto, California $343M AUM 33.47% 1-Year Est. Return
CPA
Court Place Advisors Ellicott City, Maryland $332M AUM 16.16% 1-Year Est. Return
AACP
Advantage Alpha Capital Partners San Francisco, California $332M AUM 12.78% 1-Year Est. Return

Shilanski & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Shilanski & Associates held 109 positions worth $350M, up 9.2% from $321M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Shilanski & Associates's Q2 2025 filing shows 5 new, 54 increased, 45 reduced and 1 closed positions. Its largest new stake was Oracle: 1,376 shares worth $301K. The largest sale was Merck, an estimated $215K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Staples and Financials.

  • Shilanski & Associates's largest Q2 2025 buy was Oracle: 1,376 shares worth $301K.
  • Shilanski & Associates added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $963K increase.
  • Shilanski & Associates's biggest Q2 2025 reduction was Apple, cutting an estimated $174K.
  • Shilanski & Associates fully exited Merck in Q2 2025, selling an estimated $215K.
  • Shilanski & Associates's ten largest holdings make up 43% of its $350M portfolio in Q2 2025.
  • Shilanski & Associates opened 5 new positions and closed 1 in Q2 2025.
  • Shilanski & Associates's portfolio value rose 9.2% quarter-over-quarter to $350M.

Based on Shilanski & Associates's 13F filing for Q2 2025, filed 1 Aug 2025.